The Neuroendocrine Tumor Research Foundation (NETRF) is the leading global nonprofit organization dedicated to funding research for neuroendocrine cancer. Since 2005, NETRF has invested more than $42 million in research at leading institutions around the world to accelerate breakthroughs in early detection, new treatments, and precision medicine. In addition to advancing groundbreaking science, NETRF provides trusted patient education resources and support for patients, families, and caregivers affected by neuroendocrine cancer.